Mbx Biosciences Inc (MBX)
$55.87 +2.44% Close Oct 30, 2026 Live
Mbx Biosciences stock today
Mbx Biosciences closed at $55.87 on October 30, 2026, up 2.44% on the day. Over the past year it returned +156.4% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.66 billion.
$20.00$40.00$60.00
NovJan 2026MarMayJulSep
| Period | MBX | S&P 500 (SPY) |
|---|---|---|
| 1 month | -4.7% | -0.9% |
| 3 months | -15.9% | +2.1% |
| Year to date | +77.1% | +11.7% |
| 1 year | +156.4% | +12.4% |
Key statistics
- Market value
- $2.66B
- 52-week range
- $20.61 to $70.70
- Next report
- Nov 5, 2026 (estimated)
About Mbx Biosciences
Develops therapeutics for metabolic and inflammatory diseases.
Sector: Health Care
More on Mbx Biosciences
- Returns: what $1,000 became$1,000 one year ago is $2,564 today
No forecast, no recommendation. This page describes Mbx Biosciences Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.